Modulation of phenotype and function of dendritic cells by a therapeutic synthetic killer peptide

Journal of Leukocyte Biology

Volumn 79, Issue 1, 2006, Pages 40-45

  Cenci, Elio ^a   Pericolini, Eva ^a   Mencacci, Antonella ^a   Conti, Stefania ^b   Magliani, Walter ^b   Bistoni, Francesco ^a   Polonelli, Luciano ^b   Vecchiarelli, Anna ^a  

^a UNIVERSITY OF PERUGIA   (Italy)

^b UNIVERSITY OF PARMA   (Italy)

Author keywords

Antifungal compounds; Antimicrobial peptides; Killer mimotopes

Indexed keywords

ANTIBODY; ANTIFUNGAL AGENT; B7 ANTIGEN; BETA GLUCAN; CD16 ANTIGEN; CD32 ANTIGEN; CD4 ANTIGEN; CD40 ANTIGEN; CD86 ANTIGEN; CD8ALPHA ANTIGEN; INTRACELLULAR ADHESION MOLECULE GRABBING NONINTEGRIN R1 ANTIBODY; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; MYCOTOXIN; POLYPEPTIDE ANTIBIOTIC AGENT; SYNTHETIC KILLER PEPTIDE; SYNTHETIC PEPTIDE; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; BACTERICIDAL ACTIVITY; CONTROLLED STUDY; DENDRITIC CELL; DRUG BINDING; DRUG EFFECT; FUNGAL CELL; IMMUNOCOMPETENT CELL; IMMUNOMODULATION; LYMPHOCYTE; LYMPHOCYTE PROLIFERATION; MACROPHAGE; MOUSE; NEUTROPHIL; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL;

ANIMALS; ANTIFUNGAL AGENTS; BETA-GLUCANS; CELL PROLIFERATION; CELLS, CULTURED; DENDRITIC CELLS; HISTOCOMPATIBILITY ANTIGENS CLASS II; IMMUNITY, CELLULAR; LEUKOCYTES; MICE; MICE, INBRED BALB C; MYCOSES; OLIGOPEPTIDES; RECEPTORS, IGG;

ANIMALIA; MURINAE;

EID: 30144441771     PISSN: 07415400     EISSN: None     Source Type: Journal    
DOI: 10.1189/jlb.0205113     Document Type: Article

References (33)

1. Magliani, W., Conti, S., Gerloni, M., Bertolotti, D., Polonelli, L. (1997) Yeast killer systems. Clin. Microbiol. Rev. 10, 369-400.
2. Polonelli, L., Morace, G. (1987) Production and characterization of yeast killer toxin monoclonal antibodies. J. Clin. Microbiol. 25, 460-462.
3. Polonelli, L., Morace, G. (1988) Yeast killer toxin-like anti-idiotypic antibodies. J. Clin. Microbiol. 26, 602-604.
4. Polonelli, L., Conti, S., Gerloni, M., Magliani, W., Castagnola, M., Morace, G., Chezzi, C. (1991) 'Antibiobodies': antibiotic-like anti-idiotypic antibodies. J. Med. Vet. Mycol. 29, 235-242.
5. Polonelli, L., Lorenzini, R., De Bernardis, F., Gerloni, M., Conti, S., Morace, G., Magliani, W., Chezzi, C. (1993) Idiotypic vaccination: immunoprotection mediated by anti-idiotypic antibodies with antibiotic activity. Scand. J. Immunol. 37, 105-110.
6. Polonelli, L., De Bernardis, F., Conti, S., Boccanera, M., Gerloni, M., Morace, G., Magliani, W., Chezzi, C., Cassone, A. (1994) Idiotypic intravaginal vaccination to protect against candidal vaginitis by secretory, yeast killer toxin-like anti-idiotypic antibodies. J. Immunol. 152, 3175-3182.
7. Polonelli, L., Seguy, N., Conti, S., Gerloni, M., Bertolotti, D., Cantelli, C., Magliani, W., Cailliez, J. C. (1997) Monoclonal yeast killer toxin-like candidacidal anti-idiotypic antibodies. Clin. Diagn. Lab. Immunol. 4, 142-146.
8. Magliani, W., Conti, S., de Bernardis, F., Gerloni, M., Bertolotti, D., Mozzoni, P., Cassone, A., Polonelli, L. (1997) Therapeutic potential of antiidiotypic single chain antibodies with yeast killer toxin activity. Nat. Biotechnol. 15, 155-158.
9. Polonelli, L., Magliani, W., Conti, S., Bracci, L., Lozzi, L., Neri, P., Adriani, D., De Bernardis, F., Cassone, A. (2003) Therapeutic activity of an engineered synthetic killer antiidiotypic antibody fragment against experimental mucosal and systemic candidiasis. Infect. Immun. 71, 6205-6212.
10. Cenci, E., Bistoni, F., Mencacci, A., Perito, S., Magliani, W., Conti, S., Polonelli, L., Vecchiarelli, A. (2004) A synthetic peptide as a novel anticryptococcal agent. Cell. Microbiol. 6, 953-961.
11. Travassos, L. R., Silva, L. S., Rodrigues, E. G., Conti, S., Salati, A., Magliani, W., Polonelli, L. (2004) Therapeutic activity of a killer peptide against experimental paracoccidioidomycosis. J. Antimicrob. Chemother. 54, 956-958.
12. Engering, A., Geijtenbeek, T. B., van Kooyk, Y. (2002) Immune escape through C-type lectins on dendritic cells. Trends Immunol. 23, 480-485.
13. Maffei, A., Harris, P. E. (1998) Peptides bound to major histocompatibility complex molecules. Peptides 19, 179-198.
14. Reis e Sousa, C. (2004) Activation of dendritic cells: translating innate into adaptive immunity. Curr. Opin. Immunol. 16, 21-25.
15. Magliani, W., Conti, S., Salati, A., Arseni, S., Ravanetti, L., Frazzi, R., Polonelli, L. (2004) Engineered killer mimotopes: new synthetic peptides for antimicrobial therapy. Curr. Med. Chem. 11, 1793-1800.
16. Scott-Zaki, P., Purkall, D., Ruddy, S. (2000) Neutrophil chemotaxis and superoxide production are induced by cross-linking FcγRII receptors. Cell. Immunol. 201, 89-93.
17. van Kooyk, Y., Geijtenbeek, T. B. (2003) DC-SIGN: escape mechanism for pathogens. Nat. Rev. Immunol. 3, 697-709.
18. Vieira, P. L., de Jong, E. C., Wierenga, E. A., Kapsenberg, M. L., Kalinski, P. (2000) Development of Th1-inducing capacity in myeloid dendritic cells requires environmental instruction. J. Immunol. 164, 4507-4512.
19. Kadowaki, N., Ho, S., Antonenko, S., Malefyt, R. W., Kastelein, R. A., Bazan, F., Liu, Y. J. (2001) Subsets of human dendritic cell precursors express different Toll-like receptors and respond to different microbial antigens. J. Exp. Med. 194, 863-869.
20. Kalinski, P., Hilkens, C. M., Wierenga, E. A., Kapsenberg, M. L. (1999) T-cell priming by type-1 and type-2 polarized dendritic cells: the concept of a third signal. Immunol. Today 20, 561-567.
21. Liu, Y. J., Kadowaki, N., Rissoan, M. C., Soumelis, V. (2000) T cell activation and polarization by DC1 and DC2. Curr. Top. Microbiol. Immunol. 251, 149-159.
22. Moser, M., Murphy, K. M. (2000) Dendritic cell regulation of TH1-TH2 development. Nat. Immunol. 1, 199-205.
23. Cella, M., Scheidegger, D., Palmer-Lehmann, K., Lane, P., Lanzavecchia, A., Alber, G. (1996) Ligation of CD40 on dendritic cells triggers production of high levels of interleukin-12 and enhances T cell stimulatory capacity: T-T help via APC activation. J. Exp. Med. 184, 747-752.
24. Koch, F., Stanzl, U., Jennewein, P., Janke, K., Heufler, C., Kampgen, E., Romani, N., Schuler, G. (1996) High level IL-12 production by murine dendritic cells: upregulation via MHC class II and CD40 molecules and downregulation by IL-4 and IL-10. J. Exp. Med. 184, 741-746.
25. Snijders, A., Kalinski, P., Hilkens, C. M., Kapsenberg, M. L. (1998) High-level IL-12 production by human dendritic cells requires two signals. Int. Immunol. 10, 1593-1598.
26. Hilkens, C. M., Kalinski, P., de Boer, M., Kapsenberg, M. L. (1997) Human dendritic cells require exogenous interleukin-12-inducing factors to direct the development of naive T-helper cells toward the Th1 phenotype. Blood 90, 1920-1926.
27. Sansom, D. M., Manzotti, C. N., Zheng, Y. (2003) What's the difference between CD80 and CD86? Trends Immunol. 24, 314-319.
28. Heath, W. R., Belz, G. T., Behrens, G. M., Smith, C. M., Forehan, S. P., Parish, I. A., Davey, G. M., Wilson, N. S., Carbone, F. R., Villadangos, J. A. (2004) Cross-presentation, dendritic cell subsets, and the generation of immunity to cellular antigens. Immunol. Rev. 199, 9-26.
29. Maldonado-Lopez, R., De Smedt, T., Michel, P., Godfroid, J., Pajak, B., Heirman, C., Thielemans, K., Leo, O., Urbain, J., Moser, M. (1999) CD8α+ and CD8α- subclasses of dendritic cells direct the development of distinct T helper cells in vivo. J. Exp. Med. 189, 587-592.
30. Pulendran, B., Smith, J. L., Caspary, G., Brasel, K., Pettit, D., Maraskovsky, E., Maliszewski, C. R. (1999) Distinct dendritic cell subsets differentially regulate the class of immune response in vivo. Proc. Natl. Acad. Sci. USA 96, 1036-1041.
31. Tanaka, Y., Dowdy, S. F., Linehan, D. C., Eberlein, T. J., Goedegebuure, P. S. (2003) Induction of antigen-specific CTL by recombinant HIV trans-activating fusion protein-pulsed human monocyte-derived dendritic cells. J. Immunol. 170, 1291-1298.
32. Lauvau, G., Glaichenhaus, N. (2004) Mini-review: presentation of pathogen-derived antigens in vivo. Eur. J. Immunol. 34, 913-920.
33. Harding, C. V. (1993) Cellular and molecular aspects of antigen processing and the function of class II MHC molecules. Am. J. Respir. Cell Mol. Biol. 8, 461-467.